- $7.01bn
- $14.04bn
- $7.21bn
- 77
- 81
- 98
- 98
Annual income statement for UGI, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Other Revenue | |||||
Total Revenue | 6,559 | 7,447 | 10,106 | 8,928 | 7,210 |
Cost of Revenue | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,577 | 5,097 | 8,451 | 10,381 | 6,449 |
Operating Profit | 982 | 2,350 | 1,655 | -1,453 | 761 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 667 | 1,989 | 1,387 | -1,837 | 340 |
Provision for Income Taxes | |||||
Net Income After Taxes | 532 | 1,444 | 1,074 | -1,502 | 269 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 532 | 1,467 | 1,073 | -1,502 | 269 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 532 | 1,467 | 1,073 | -1,502 | 269 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.9 | 7.43 | 5.01 | -4.52 | 2.94 |
Dividends per Share |